REQUEST A DEMO
Total
USD $0.00
Search more companies

Sopharmacy 14 EOOD (Bulgaria)

Main Activities: Pharmacies and Drug Stores
Full name: Sopharmacy 14 EOOD Profile Updated: September 08, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Sopharmacy 14 EOOD is an enterprise based in Bulgaria. Its main office is in Sofia. It operates in the Pharmacies and Drug Stores industry. It was first established on 2017. It currently has a total number of 34 (2023) employees. In 2022, the company reported a net sales revenue increase of 12.23%. Its total assets grew by 7.97% over the same period. Sopharmacy 14 EOOD’s net profit margin increased by 1.1% in 2022.

Headquarters
zh.k. Iztok Lachezar Stanchev 5 Sofarma Biznes Tauars Sgrada A et. 12
Sofia; Sofia - city; Postal Code: 1756

Contact Details: Purchase the Sopharmacy 14 EOOD report to view the information.

Basic Information
Total Employees:
Purchase the Sopharmacy 14 EOOD report to view the information.
Outstanding Shares:
Purchase the Sopharmacy 14 EOOD report to view the information.
Registered Capital:
Purchase the Sopharmacy 14 EOOD report to view the information.
Incorporation Date:
2017
Key Executives
Purchase this report to view the information.
Manager
Company Performance
Financial values in the chart are available after Sopharmacy 14 EOOD report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BGN. Absolute financial data is included in the purchased report.
Net sales revenue
12.23%
Total operating revenue
12.33%
Net Profit (Loss) for the Period
200.62%
Total assets
7.97%
Total equity
168.55%
Operating Profit Margin (ROS)
-0.77%
Net Profit Margin
1.1%
Return on Equity (ROE)
6.04%
Quick Ratio
0.54%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?